For Quick Alerts
For Daily Alerts

Wockhardt dips 5% after UK medicines regulator withdraw certification

By Religare

Shares of drug maker Wockhardt tanked 5 per cent in early trade on Bombay Stock Exchange (BSE) after UK's medicines regulator withdrew its certification to the company's manufacturing facility situated at L1, MIDC, Chikalthana, Aurangabad.

"The UK's Medicines and Healthcare Products Regulatory Agency (UKMHRA)...has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at L1, MIDC, Chikalthana, Aurangabad and will be issuing a restricted GMP Certificate to the site along with a statement of non-compliance for the said site," Wockhardt said in a filing to BSE.


Weighed down by development, shares of the company declined as much as 4.99 per cent to trade at Rs 499.30 a piece on the BSE.

In a similar fashion, shares of the company slipped 4.99 per cent to Rs 499.65 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 20,608.06, up 79.47 points or 0.39 per cent at 9:50 hours.

Read more about: wockhardt
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more